全球微流体市场规模、份额、成长分析，按技术（医疗和非医疗）、按材料（硅、玻璃）划分 - 产业预测 2024-2031

Global Microfluidics Market Size, Share, Growth Analysis, By Technology(Medical and Non- Medical), By Material(Silicon, Glass) - Industry Forecast 2024-2031

出版日期: 2024年04月07日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球微流控市场规模为206.3亿美元，预计将从2023年的232.5亿美元成长到2031年的582.3亿美元，在预测期内（2024-2031年）复合年增长率为12.22%。

与传统流体测量工具相比，微流体技术需要更少的样品和更小的仪器，提供增强的参数控制和资料质量，使其成为 PCR 扩增、细胞分离和 DNA 分析的普遍选择。《PLOS One》上发表的一项研究预测，到2025 年，法国将有约280 万例慢性阻塞性肺病(COPD) 病例，透过使用微流控晶片和最少的血液样本进行COPD 检测的需求增加，将推动市场成长。澳洲的失智症发生率预计将从2022 年的487,500 例上升到2058 年的110 万例，因此越来越需要有效的药物发现、筛选方法和毒理学研究，从而推动了对能够促进骨骼、神经胶质细胞研究的微流体系统的需求。总体而言，微流体设备在不同研究和诊断领域的广泛使用预计将推动市场成长。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Danaher Corporation (US)
Thermo Fisher Scientific Inc. (US)
Agilent Technologies, Inc. (US)
PerkinElmer, Inc. (US)
Bio-Rad Laboratories, Inc. (US)
Dolomite Microfluidics (UK)
Micronit Microfluidics BV (Netherlands)
Fluidigm Corporation (US)
Sphere Fluidics Ltd. (UK)
Fluigent (France)
Elveflow (France)
Cellix Ltd. (Ireland)
MicroLIQUID SL (Spain)
Abbott Laboratories (US)
Roche Diagnostics (Switzerland)
uFluidix (Canada)
microfluidic ChipShop GmbH (Germany)
Micralyne Inc. (Canada)
microLIQUID (Spain)
MicruX Technologies (Spain)
MiniFAB Pty Ltd. (Australia)
Micromotive GmbH (Germany)

简介目录

Product Code: SQMIG35A2288

Global Microfluidics Market size was valued at USD 20.63 billion in 2022 and is poised to grow from USD 23.25 billion in 2023 to USD 58.23 billion by 2031, growing at a CAGR of 12.22% during the forecast period (2024-2031).

Microfluidic technology, requiring fewer samples and smaller instruments compared to traditional fluid measurement tools, offers enhanced parameter control and data quality, making it a prevalent choice in PCR amplification, cell separation, and DNA analysis. A study published in PLOS One forecasts approximately 2.8 million cases of chronic obstructive pulmonary disease (COPD) in France by 2025, driving market growth through increased demand for COPD testing using microfluidic chips and minimal blood samples. With dementia rates in Australia expected to escalate from 487,500 cases in 2022 to 1.1 million by 2058, there is a rising necessity for efficient medication discovery, screening methods, and toxicological investigations, propelling the demand for microfluidic systems capable of facilitating research on skeletal, glial, and endothelial cells to explore organogenesis and disease etiology while ensuring fluid isolation of muscle cells. Overall, the expanding utilization of microfluidic devices across diverse research and diagnostic domains is anticipated to fuel market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidics Market Segmental Analysis

Global Microfluidics Market is segmented on the basis of technology, material, application type and region. By technology, the market is segmented into medical and non-medical. By material, market is segmented into silicon, glass, polymer, PDMS, others. By application, the marker is segmented into lab-on-a-chip, organs-on-chip, continuous flow microfluidics, optofluidic & microfluidics, acoustofluidics & microfluidics, electrophoresis & microfluidics. By type, the market is segmented into microfluidics chips, microfluidics sensors, microfluidics pumps, others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Microfluidics Market

The rising adoption of microfluidic devices in personalized medicine stems from their capacity to deliver both high-throughput and high-quality outcomes. As the demand for personalized medical solutions continues to surge, there is an anticipation of substantial growth in the microfluidic device market to meet these evolving needs.

Restraints in the Global Microfluidics Market

The intricacies of manufacturing microfluidic devices demand precision and expertise, posing challenges for companies aiming to expand production and reduce expenses due to the complexity involved in the process.

Market Trends of the Global Microfluidics Market

Point-of-care testing (POCT) involves medical diagnostic procedures conducted outside traditional clinical laboratory settings, such as in a doctor's office, hospital ward, or home environment, aiming for greater convenience and rapid results. The rising popularity of POCT is driving demand for microfluidic devices, which are particularly suitable for such testing scenarios, owing to their agility and efficiency.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Microfluidics Market by Technology

Market Overview
Medical and Non- Medical

Global Microfluidics Market by Material

Market Overview
Silicon
Glass
Polymer
PDMS
Others

Global Microfluidics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dolomite Microfluidics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micronit Microfluidics BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sphere Fluidics Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluigent (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elveflow (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellix Ltd. (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroLIQUID SL (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
uFluidix (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
microfluidic ChipShop GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micralyne Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
microLIQUID (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicruX Technologies (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MiniFAB Pty Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micromotive GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments